Jin Yang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	60,678	66,504	66,805	70,257	78,689	78,242
Market Cap Growth	-19.50%	-0.45%	-4.91%	-10.72%	0.57%	59.09%
Enterprise Value	133,315	148,150	73,349	78,626	79,706	80,961
Last Close Price	4700.00	5652.12	5859.13	6021.93	6356.42	6228.17
PE Ratio	10.10	2.24	5.41	5.71	8.25	14.96
PS Ratio	0.52	0.59	0.71	0.92	1.25	1.58
PB Ratio	0.48	0.56	0.75	0.91	1.21	1.62
P/TBV Ratio	0.50	0.58	0.80	0.95	1.24	1.67
P/FCF Ratio	47.64	-	8.51	16.61	-	16.03
P/OCF Ratio	21.47	5.20	7.83	9.43	39.93	12.53
EV/Sales Ratio	1.14	1.31	0.78	1.03	1.27	1.64
EV/EBITDA Ratio	12.84	10.79	6.47	5.86	8.74	12.83
EV/EBIT Ratio	15.74	12.65	8.45	7.06	11.45	19.00
EV/FCF Ratio	104.67	-	9.34	18.59	-	16.59
Debt / Equity Ratio	0.61	0.67	0.09	0.26	0.31	0.13
Debt / EBITDA Ratio	7.44	5.80	0.69	1.49	2.20	0.97
Debt / FCF Ratio	60.65	-	1.00	4.72	-	1.26
Net Debt / Equity Ratio	0.57	0.65	-0.01	0.12	0.08	0.02
Net Debt / EBITDA Ratio	7.00	5.66	-0.07	0.71	0.56	0.13
Net Debt / FCF Ratio	57.03	-1.00	-0.10	2.24	-9.41	0.17
Asset Turnover	0.51	0.65	0.80	0.72	0.74	0.71
Inventory Turnover	2.75	2.72	2.24	2.50	3.41	3.19
Quick Ratio	0.34	1.44	1.24	0.98	1.16	1.11
Current Ratio	0.52	2.19	1.96	1.50	1.51	1.55
Return on Equity (ROE)	4.48%	28.46%	14.84%	17.23%	16.79%	11.38%
Return on Assets (ROA)	2.31%	4.21%	4.63%	6.54%	5.12%	3.81%
Return on Invested Capital (ROIC)	3.56%	6.57%	9.92%	11.98%	9.16%	7.07%
Return on Capital Employed (ROCE)	5.90%	5.60%	9.10%	13.30%	9.80%	8.00%
Earnings Yield	9.08%	44.65%	18.47%	17.52%	12.12%	6.68%
FCF Yield	2.10%	-116.19%	11.75%	6.02%	-0.69%	6.24%
Payout Ratio	31.12%	5.45%	13.10%	9.08%	11.72%	21.38%
Buyback Yield / Dilution	5.70%	1.17%	7.18%	-17.77%	-2.12%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.